EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Copper-coordinated nanomedicine for the concurrent treatment of lung cancer through the induction of cuproptosis and apoptosis

Pei Huang, Gongfa Wu, Min Huang, Yating Deng, Xuming Chen, Guodong Ye, Xiyong Yu, He Wang, Huaying Wen, Yi Zhou

European Journal of Pharmaceutical Sciences · 2025

DOI: 10.1016/j.ejps.2024.106942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2025. Verfasst von Pei Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Fifth Affiliated Hospital, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and …. Hauptthemen laut MEDLINE: Copper, Apoptosis, Doxorubicin, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Municipal Science and Technology Project, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The resistance of tumor cells to apoptosis often leads to chemoresistance and treatment failure in clinic. In this study, we have developed a Cu2+-coordinated lignosulfonate (CLS) /doxorubicin (DOX) biological complex (referred to as LCD) with the aim of overcoming cellular resistance to apoptosis for combined lung cancer therapy. The copper complexes modified by CLS exhibit significant water solubility and excellent in vivo biocompatibility. The proportion of copper in the composite is simultaneously increased. Due to the coordination and π-π stacking effects, the self-assembled LCD exhibits nanometer-scale particle size, a narrow and homogeneous grain distribution, as well as excellent dispersion stability. Furthermore, LCD has the potential to disassemble in the presence of high levels of glutathione (GSH) and low pH, leading to effective drug release. Cu2+-mediated cuproptosis can lead to the down-regulation of FDX1 and DLAT protein expression by reducing mitochondrial membrane potential, resulting in non-apoptotic programmed cell death (PCD) regardless of cellular resistance to apoptosis. Moreover, the released DOX not only exhibits a preference for localizing in the cell nucleus to induce apoptosis for combined chemotherapy, but also generates a substantial amount of H2O2. This H2O2 further produces ROS to induce apoptosis through Fenton reaction with Cu2+. LCD demonstrates significant superiority over monotherapy in inhibiting tumor growth while minimizing systemic toxicity through the combined action of cuproptosis and apoptosis. This study may provide a potential avenue for the advancement of self-delivery nanomedicine to overcome resistance to apoptosis in tumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperApoptosisDoxorubicinLung NeoplasmsNanomedicineAnimalsHumansCell Line, TumorMice, Inbred BALB CLigninMiceA549 CellsDrug LiberationMembrane Potential, MitochondrialAntineoplastic AgentsMice, Nude

Stichwörter der Autor:innen

ApoptosisCuproptosisResistance to apoptosisSelf-delivery

Substanzen

CopperDoxorubicinLigninAntineoplastic Agents

Autor:innen und Institutionen

  • The Fifth Affiliated Hospital, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, and School of Pharmaceuti…
  • The Fourth Affiliated Hospital, Guangzhou Medical University, Guangdong, 511300, Guangzhou, PR China.
  • The Second Affiliated Hospital, Guangzhou Medical University, Guangdong, 510260, Guangzhou, PR China.

Förderung

  • Guangzhou Municipal Science and Technology Project
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Huang, P., Wu, G., Huang, M., Deng, Y., Chen, X., Ye, G., Yu, X., Wang, H., Wen, H., & Zhou, Y. (2025). Copper-coordinated nanomedicine for the concurrent treatment of lung cancer through the induction of cuproptosis and apoptosis. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2024.106942

Vancouver

Huang P, Wu G, Huang M, Deng Y, Chen X, Ye G, et al. Copper-coordinated nanomedicine for the concurrent treatment of lung cancer through the induction of cuproptosis and apoptosis. European Journal of Pharmaceutical Sciences. 2025. doi:10.1016/j.ejps.2024.106942

BibTeX
@article{Huang2025,
  author = {Huang, Pei and Wu, Gongfa and Huang, Min and Deng, Yating and Chen, Xuming and Ye, Guodong and Yu, Xiyong and Wang, He and Wen, Huaying and Zhou, Yi},
  title = {Copper-coordinated nanomedicine for the concurrent treatment of lung cancer through the induction of cuproptosis and apoptosis},
  journal = {European Journal of Pharmaceutical Sciences},
  year = {2025},
  doi = {10.1016/j.ejps.2024.106942}
}
Kostenlos starten →